Dow Down 1.40% Nasdaq Down 1.59%

Cellceutix Corporation (CTIX)

-Other OTC
2.96 0.06(1.99%) Oct 1, 3:59PM EDT
|Pre-Market : NaN
Prev Close:3.02
Open:3.00
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:-0.27
Next Earnings Date:N/A
Day's Range:2.77 - 3.00
52wk Range:1.40 - 3.03
Volume:637,143
Avg Vol (3m):346,781
Market Cap:330.59M
P/E (ttm):N/A
EPS (ttm):-0.10
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CTIX

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (0-00-31) :N/A
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cellceutix Corporation, a clinical stage biopharmaceutical company, focuses on discovering and developing small molecule drugs to treat drug-resistant cancers, psoriasis, autism, and inflammatory diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback